Discover how EZH2 inhibition unexpectedly enhances PD-L1 protein stability through USP22-mediated deubiquitination in colorectal cancer, revealing new therapeutic strategies.
Discover how Cbl-b deficiency makes T cells resistant to PD-L1-mediated inhibition and its implications for cancer immunotherapy.